BREAKING
Fiserv (FISV) Earnings: 4Q25 Key Numbers 1 hour ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 2 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 14 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 14 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 17 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 19 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 21 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 23 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 1 day ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 day ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 1 hour ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 2 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 14 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 14 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 17 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 19 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 21 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 23 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 1 day ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 day ago
ADVERTISEMENT
Market News

Earnings: A snapshot of Bath & Body Works’ Q1 2023 financial results

Bath & Body Works Inc. (NYSE: BBWI), a provider of personal care and home fragrance products, has announced financial results for the first quarter of 2023. First-quarter net sales decreased 4% annually to $1.40 billion from $1.45 billion in the comparable period of 2022 Net income was $81 million in the April quarter, compared to $155 […]

May 19, 2023 1 min read

Bath & Body Works Inc. (NYSE: BBWI), a provider of personal care and home fragrance products, has announced financial results for the first quarter of 2023.

  • First-quarter net sales decreased 4% annually to $1.40 billion from $1.45 billion in the comparable period of 2022
  • Net income was $81 million in the April quarter, compared to $155 million in the prior-year quarter
  • On an adjusted basis, earnings nearly halved to $0.35 per share from $0.64 per share last year
  • Excluding the gain on the early extinguishment of debt, adjusted earnings per share fell to $0.33 from $0.64 per share
  • The company reaffirmed its earlier guidance of flat net sales to a mid-single-digit decline for fiscal 2023
  • Full‐year earnings per share, on a reported basis, are expected to be between $2.70 and $3.10, compared to $3.40 in 2022
  • The company expects full‐year 2023 adjusted earnings per share to be in the range of $2.68 to $3.08
ADVERTISEMENT